ADHD drug gets 23.5% production boost from DEA amid shortage(arstechnica.com)
arstechnica.com
ADHD drug gets 23.5% production boost from DEA amid shortage
https://arstechnica.com/science/2024/09/adhd-drug-gets-23-5-production-boost-from-dea-amid-shortage/
3 comments
Alternative title: "Global shortage of ADHD medication caused by DEA restrictions"
A more accurate title, as well.
Vyvanse (lisdexamfetamine), its generic versions, and d-amphetamine, which is needed for production of lisdexamfetamine.